InhalPlus Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $562K

  • Investors
  • 7

InhalPlus General Information

Description

Operator of a medical device technology intended to improve non-invasive inhalation therapy for preterm infants, newborns, and adults requiring respiratory support. The company offers a patented aerosol delivery system with bypass technology that prevents medication dilution in ventilation circuits, supports continuous respiratory assistance, and delivers concentrated medication directly to the lungs, enabling hospitals, neonatal intensive care units, and respiratory care providers to improve drug delivery and reduce reliance on invasive treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Fichtestraße 37
  • 30625 Hanover
  • Germany
Primary Industry
Medical Supplies
Other Industries
Therapeutic Devices
Drug Delivery
Vertical(s)
Corporate Office
  • Fichtestraße 37
  • 30625 Hanover
  • Germany

InhalPlus Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InhalPlus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round 26-Oct-2026 $562K Completed Generating Revenue
6. Accelerator/Incubator 15-May-2025 Completed Startup
5. Seed Round 01-May-2025 Completed Startup
4. Grant 01-Apr-2025 Completed Startup
3. Grant 01-Dec-2024 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2023 Completed Startup
To view InhalPlus’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

InhalPlus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InhalPlus Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
NBank Capital Venture Capital Minority
HGS START accelerator Accelerator/Incubator Minority
Fraunhofer Venture Venture Capital Minority
Institute for Biomedical Translation Corporation
Germany's Federal Ministry of Economics and Technology Government
You’re viewing 5 of 7 investors. Get the full list »

InhalPlus FAQs

  • When was InhalPlus founded?

    InhalPlus was founded in 2023.

  • Where is InhalPlus headquartered?

    InhalPlus is headquartered in Hanover, Germany.

  • What is the size of InhalPlus?

    InhalPlus has 4 total employees.

  • What industry is InhalPlus in?

    InhalPlus’s primary industry is Medical Supplies.

  • Is InhalPlus a private or public company?

    InhalPlus is a Private company.

  • What is InhalPlus’s current revenue?

    The current revenue for InhalPlus is .

  • How much funding has InhalPlus raised over time?

    InhalPlus has raised $580K.

  • Who are InhalPlus’s investors?

    NBank Capital, HGS START accelerator, Fraunhofer Venture, Institute for Biomedical Translation, and Germany's Federal Ministry of Economics and Technology are 5 of 7 investors who have invested in InhalPlus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process